0000000000378403

AUTHOR

José Guevara-gonzález

showing 3 related works from this author

The Effects of Probiotics and Prebiotics on Gastrointestinal and Behavioural Symptoms in Autism Spectrum Disorder

2021

Background: Autism Spectrum Disorders (ASDs) are a group of prevalent neuropsychiatric disorders. They present a complex and unknown etiology, which in most cases includes significant peripheral alterations outside the brain such as in the composition of gut microbiota. Because the gut microbiota is involved in modulating the gut-brain axis, several studies have suggested that the microbiome in the gut can modify metabolites which are able to cross the blood-brain barrier and modulate brain function. Methods: We reviewed the current evidence regarding microbiota alterations in patients with ASD and the effects of the administration of probiotics and prebiotics in these patients, both in te…

Autism Spectrum DisorderSynbioticsmedicine.medical_treatmentGut–brain axisBehavioral SymptomsGut floraBioinformaticslaw.inventionProbioticlawmedicineHumansPharmacology (medical)MicrobiomeGeneral Pharmacology Toxicology and Pharmaceuticsbiologybusiness.industryProbioticsPrebioticbiology.organism_classificationmedicine.diseaseGastrointestinal MicrobiomePrebioticsAutism spectrum disorderAutismbusinessCurrent Reviews in Clinical and Experimental Pharmacology
researchProduct

Febrile seizure and related syndromes

2018

Abstract Febrile seizures (FS) are the result of particular sensitivity to fever in the developing brain, have a major genetic predisposition, and nearly always have a benign outcome. Febrile seizures are the most common for of seizures in childhood. They have been observed in 2–6% of children before the age of 5 years, but in some populations this figure increase to 15%. Febrile seizures could be the first manifestations of epilepsy. About 13% of epileptic patients have a history of febrile seizures, and 30% have had recurrent febrile seizures Their phenotypic characteristics allow, in the majority of cases, a classification of the seizure, an elaboration of a prognosis and to assume a spe…

Pediatricsmedicine.medical_specialtybusiness.industryGeneral Neurosciencemedicine.disease03 medical and health sciencesPsychiatry and Mental healthEpilepsy0302 clinical medicineDravet syndrome030225 pediatricsAnesthesiaFebrile seizureEpilepsy syndromesGenetic predispositionMedicineMultifactorial InheritanceNeurology (clinical)Risk factorbusiness030217 neurology & neurosurgeryMedical literatureNeurology, Psychiatry and Brain Research
researchProduct

First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder

2019

Systemic primary carnitine deficiency (PCD) is a genetic disorder caused by decreased or absent organic cation transporter type 2 (OCTN2) carnitine transporter activity, resulting in low serum carnitine levels and decreased carnitine accumulation inside cells. In early life, PCD is usually diagnosed as a metabolic decompensation, presenting as hypoketotic hypoglycemia, Reye syndrome, or sudden infant death; in childhood, PCD presents with skeletal or cardiac myopathy. However, the clinical presentation of PCD characterized by autism spectrum disorder (ASD) with intellectual disability (ID) has seldom been reported in the literature. In this report, we describe the clinical features of a sev…

Pediatricsmedicine.medical_specialtymuscleautismrare diseaseCase ReportSLC22A5lcsh:RC321-57103 medical and health sciences0302 clinical medicineSystemic primary carnitine deficiencymedicineReye SyndromeCarnitineMyopathylcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbiologybusiness.industryGeneral Neurosciencecarnitinemedicine.diseaseAutism spectrum disorderintellectual disabilitybiology.proteinAutismmedicine.symptombusinessPrimary Carnitine Deficiency030217 neurology & neurosurgerymedicine.drugBrain Sciences
researchProduct